🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06751498
Recruiting Observational

The Value of a Convolutional Neural Network-Based Renal Artery Perfusion Model in Predicting Renal Function After Partial Nephrectomy: A Prospective Study

NCT06751498 · tracked via the Priya Life Science China tracker
Sponsor
Shao Pengfei
Phase
Observational
Started
2025-01-01
Last updated
2025-04-17

Condition(s) studied

Renal Cell Cancer

Study summary

The goal of this observational study is to develop a CNN-based machine module to predict postoperative fractional renal function in people who are proposed to undergo partial nephrectomy. The main question it aims to answer is:

• Does this machine learning model accurately predict renal function after partial nephrectomy?

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * people with stage cT1 renal tumors confirmed by preoperative CT or MR * people who are proposed to undergoing partial nephrectomy * localized renal tumors without lymph node and distant metastases as defined by NCCN guidelines * ECOG score of 0 or 1 * Life expectancy greater than 10 years Exclusion Criteria: * people with surgically unresectable lesions * people with Abnormal preoperative renal function, eGFR(estimated by CKD-EPI)\<90ml/min/1.73m2 * people who receive preoperative molecular targeted therapy, immunotherapy, chemotherapy * people with any contraindications to surgery * people who convert to radical nephrectomy during surgery * people who receive molecular targeted therapy, immunotherapy or chemotherapy during the postoperative follow-up period * people with serious systemic disease

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital) Nanjing Jiangsu Recruiting
The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital) Nanjing Jiangsu Not Yet Recruiting

More Shao Pengfei trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06751498 on ClinicalTrials.gov ↗ ← All trials in China